The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) has received $24M from the Coalition for Epidemic Preparedness Innovations (CEPI) to lead pandemic preparedness research. VIDO will use this funding to continue developing its pan-sarbecovirus vaccine, which is designed to protect against different types of coronaviruses. VIDO and CEPI will also ensure that the project results are published in an open access format to benefit the global scientific community. “By focusing on broadly protective coronavirus vaccines, we are taking a critical step toward safeguarding humanity against future pandemics,” said VIDO Director Volker Gerdts. “Collaboration like this underscores the importance of international partnerships in developing innovative solutions to complex health threats.”